These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30165067)

  • 1. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
    El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
    J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery.
    Song Y; Nagai N; Saijo S; Kaji H; Nishizawa M; Abe T
    Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():1-12. PubMed ID: 29636124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
    Shokry M; Hathout RM; Mansour S
    Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
    Tan G; Yu S; Pan H; Li J; Liu D; Yuan K; Yang X; Pan W
    Int J Biol Macromol; 2017 Jan; 94(Pt A):355-363. PubMed ID: 27760378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
    Saroha A; Pandey P; Kaushik D
    Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
    Cheng YH; Tsai TH; Jhan YY; Chiu AW; Tsai KL; Chien CS; Chiou SH; Liu CJ
    Carbohydr Polym; 2016 Jun; 144():390-9. PubMed ID: 27083831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication.
    Hathout RM; Gad HA; Abdel-Hafez SM; Nasser N; Khalil N; Ateyya T; Amr A; Yasser N; Nasr S; Metwally AA
    Int J Pharm; 2019 Feb; 556():192-199. PubMed ID: 30553005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
    Hegde RR; Bhattacharya SS; Verma A; Ghosh A
    Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
    Cheng YH; Hung KH; Tsai TH; Lee CJ; Ku RY; Chiu AW; Chiou SH; Liu CJ
    Acta Biomater; 2014 Oct; 10(10):4360-6. PubMed ID: 24914827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lollipop-Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long-Term, and NIR-Defined Glaucoma Treatment.
    Wang F; Song Y; Huang J; Wu B; Wang Y; Pang Y; Zhang W; Zhu Z; Ma F; Wang X; Zhang X
    Macromol Biosci; 2021 Nov; 21(11):e2100202. PubMed ID: 34405963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo.
    Zhang HH; Luo QH; Yang ZJ; Pan WS; Nie SF
    Drug Deliv; 2011; 18(7):502-10. PubMed ID: 21790329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: A transparent topical ocular delivery system for the treatment of glaucoma.
    Pakzad Y; Fathi M; Omidi Y; Mozafari M; Zamanian A
    Int J Biol Macromol; 2020 Sep; 159():117-128. PubMed ID: 32380105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
    Gupta H; Velpandian T; Jain S
    J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
    Tighsazzadeh M; Mitchell JC; Boateng JS
    Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma.
    Zhao J; Xiong J; Ning Y; Zhao J; Wang Z; Long L; He H; Gou J; Yin T; Tang X; Zhang Y
    Eur J Pharm Biopharm; 2023 Apr; 185():44-54. PubMed ID: 36841507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
    AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.